|
Delayed
London S.E.
03:40:40 2026-10-21 EDT
|
5-day change | 1st Jan Change | ||
| 1.150 GBX | +6.98% |
|
+9.52% | +31.43% |
| 10-12 | Tialis wins "significant" utilities contract | AN |
| 10-12 | Genedrive PLC Notes NIHR Case Study On Development, Clinical Validation And Adoption Of Genedrive MT-RNR1 ID Kit | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Medical Diagnostic & Testing Equipment
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 23.09M | - | - | - | - | - |
| 254B | |||||
| 158B | |||||
| 155B | |||||
| 66.06B | |||||
| 51.6B |
- Stock Market
- Stocks
- EHP Stock
- Charts genedrive plc
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
